A microarray approach to translational medicine in breast cancer: How representative are cell line models of clinical conditions?

Anticancer Research

Volumn 27, Issue 3 A, 2007, Pages 1295-1300

  Mehta, Jai Prakash ^a   O'Driscoll, Lorraine ^a   Barron, Niall ^a   Clynes, Martin ^a   Doolan, Padraig ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Cell cycle; Cell line; Clinical specimens; Estrogen receptor; Hierarchical clustering; Immune response; Principal component analysis; Representative model

Indexed keywords

ESTROGEN RECEPTOR;

BREAST CANCER; CANCER CELL; CELL CYCLE; CLUSTER ANALYSIS; CONFERENCE PAPER; GENE CLUSTER; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; HUMANS; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ESTROGEN;

EID: 34249308549     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba II, Tomlinson G, Tonk V, Ashfaq R, Leitch AM, Minna JD and Shay JW: Characterization of paired tumour and non-tumour cell lines established from patients with breast cancer. Int J Cancer 78(6): 766-774, 1998.
2. Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmadian M, Virmani AK, Kurvari V, Cunningham TH, Ashfaq R, Minna JD and Gazdar AF: Comparison of features of human breast cancer cell lines and their corresponding tumours. Clin Cancer Res 4(12): 2931-2938, 1998.
3. Burdall SE, Hanby AM, Lansdown MRJ and Speirs V: Breast cancer cell lines: friend or foe? Breast Cancer Res 5: 89-95, 2003.
4. Chang JC, Hilsenbeck SG and Fuqua SA: The promise of microarrays in the management and treatment of breast cancer. Breast Cancer Res 7(3): 100-104, 2005.
5. Ross DT and Perou CM: A comparison of gene expression signatures from breast tumours and breast tissue derived cell lines. Dis Markers 17(2): 99-109, 2001.
6. Dairkee SH, Ji Y, Ben Y, Moore DH, Meng Z and Jeffrey SS: A molecular signature of primary breast cancer cultures; patterns resembling tumour tissue. BMC Genomics doi:10.1186/1471-2164-5-47, 2004.
7. Wang H, Huang S, Shou J, Su EW, Onyia JE, Liao B and Li S: Comparative analysis and integrative classification of NCI60 cell lines and primary tumours using gene expression profiling data. BMC Genomics doi: 10.1186/1471-2164-7-166, 2006.
8. Sotiriou C, Wirapati P, Loi S, Harris A Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Vijver MJV, Bergh J, Piccart M and Delorenzi M: Gene expression profiling in breast cancer: Understanding the molecular basis of histological grade to improve prognosis. Nat Can Inst 98(4): 262-272, 2006.
9. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Jr JAO, Marks JR, Dressman HK, West M and Nevins JR: Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357, 2005.
10. Edgar R, Domrachev M and Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nuc Acids Res 30(1): 207-210, 2002.
11. Li C and Wong WH: Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Prot Natl Acad Sci USA 98: 31-36, 2001.
12. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC and Conklin BR: GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Gen 31(1): 19-20, 2002.
13. Ertel A, Verghese A, Byers SW, Ochs M and Tozeren A: Pathways-specific differences between tumour cell lines and normal and tumour tissue cells. Mol Cancer doi:10.1186/1476-4598-5-55, 2006.
14. Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adelaide J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D and Bertucci F: Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25(15): 2273-2284, 2006.
15. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL and Liu ET: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. PNAS 100(18): 10393-10398, 2003.